Dipal Doshi

SVP Business Planning & Dev, Amicus Therapeutics.

Companies

Azenta Life SciencesBoard member Feb 4, 2025 to now¹
Entrada Therapeutics, Inc.Board member Oct 28, 2021 to now²
Entrada Therapeutics, Inc.Chief executive officer Oct 28, 2021 to now²
Entrada Therapeutics, Inc.President Oct 28, 2021 to Dec 22, 2023²
Amicus TherapeuticsSVP Business Planning & Dev Jul 8, 2014 to Jul 9, 2015³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAzenta Life Sciences, Board member
2
SEC EDGAREntrada Therapeutics, Inc., Board member
3
SEC EDGARAmicus Therapeutics, SVP Business Planning & Dev